Select for export The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0300501 PubMed 38483940 Copy citation Copy BibTeX PLoS ONE 2024-03-13 Adam W. Levin, Rafael Lancelotta, Nathan D. Sepeda, Natalie Gukasyan, Sandeep M. Nayak, Theodore L. Wagener OpenAlex Published psilocybin DepressionMystical ExperienceClinical Trial Randomized Controlled Trial More
Select for export Impact of Psilocybin on Peripheral Cytokine Production Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0039 PubMed 40051582 Copy citation Copy BibTeX Psychedelic Medicine 2024-02-27 Dana DiRenzo, Frederick S. Barrett, Jamie Perin, Erika Darrah, Lisa Christopher-Stine, Roland R. Griffiths OpenAlex Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1199642 PubMed 37795509 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-09-18 Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, David S. Mathai, Sara So, Abigail Yaffe OpenAlex Published psilocybin DepressionAnxietyChronic Pain Observational Study More
Select for export Single-Dose Psilocybin Treatment for Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jama.2023.14530 PubMed 37651119 Copy citation Copy BibTeX JAMA 2023-08-30 Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2023.115349 PubMed 37523886 Copy citation Copy BibTeX Unknown journal 2023-07-22 Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR Europe PMC Published psilocybin DepressionMeta-AnalysisSystematic Review Meta-Analysis More
Select for export Attenuation of psilocybin mushroom effects during and after SSRI/SNRI antidepressant use Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811231179910 PubMed 37291890 Copy citation Copy BibTeX Journal of Psychopharmacology 2023-06-07 Natalie Gukasyan, Roland R. Griffiths, David B. Yaden, Denis Antoine, Sandeep M. Nayak OpenAlex Published psilocybin DepressionAnxietyAddiction Observational Study More
Select for export Serotonergic antidepressant use is associated with weaker psilocybin effects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/2zys9 Copy citation Copy BibTeX PsyArXiv 2022-10-27 Gukasyan N, Griffiths RR, Yaden DB, Antoine D, Nayak SM. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionObservational Study Observational Study More
Select for export Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811211073759 PubMed 35166158 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-01-31 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW Europe PMC Published psilocybin DepressionWellbeingSpirituality Clinical Trial More
Select for export The Potential of Psychedelics for End of Life and Palliative Care. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2021_278 PubMed 34958455 Copy citation Copy BibTeX Current topics in behavioral neurosciences 2021-12-31 Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR PubMed Published psilocybin DepressionEnd-of-Life DistressWellbeing Review Article More
Select for export Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-021-01706-y PubMed 34750350 Copy citation Copy BibTeX Translational Psychiatry 2021-11-07 Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH Europe PMC Published psilocybin DepressionBrain ImagingMechanism of Action Other More
Select for export Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-1524-2794 PubMed 34348413 Copy citation Copy BibTeX Pharmacopsychiatry 2021-08-03 Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Europe PMC Published psilocybin DepressionSafety Other More
Select for export Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder. No abstract availability was recorded for this entry. Details DOI 10.1001/jamapsychiatry.2020.4638 PubMed 33566073 Copy citation Copy BibTeX Unknown journal 2021-04-30 Davis AK, Griffiths RR. Europe PMC Published psilocybin Depression Other More
Select for export Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31234/osf.io/r726d Copy citation Copy BibTeX PsyArXiv 2021-02-23 Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionSafety Other More
Select for export Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881121991822 PubMed 33611977 Copy citation Copy BibTeX Journal of Psychopharmacology 2021-02-19 Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionReceptor Pharmacology Other More
Select for export Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2020.3285 PubMed 33146667 Copy citation Copy BibTeX JAMA Psychiatry 2020-11-03 Alan K. Davis, Frederick S. Barrett, Darrick G. May, Mary P Cosimano, Nathan D. Sepeda, Matthew W. Johnson OpenAlex Published psilocybin DepressionChronic PainConsciousness Randomized Controlled Trial More
Select for export Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2018.11.010 PubMed 30521880 Copy citation Copy BibTeX Unknown journal 2018-12-03 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionEnd-of-Life Distress Review Article More
Select for export Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/7854_2017_474 PubMed 28401522 Copy citation Copy BibTeX Unknown journal 2017-12-31 Barrett FS, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Review Article More
Select for export Potential Therapeutic Effects of Psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s13311-017-0542-y PubMed 28585222 Copy citation Copy BibTeX Unknown journal 2017-06-30 Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116684335 PubMed 28095732 Copy citation Copy BibTeX Journal of Psychopharmacology 2017-01-17 Johnson MW, Garcia-Romeu A, Johnson PS, Griffiths RR. Europe PMC Published psilocybin DepressionAddictionMechanism of Action Observational Study More
Select for export Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675513 PubMed 27909165 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
